Gut microbes and plant foods: a powerful duo for healthy aging

Gut microbiota and phytochemicals synergize to produce bioactive metabolites that combat aging, reduce inflammation, and enhance healthspan by supporting gut and systemic health.

ADC Therapeutics reveals topline Zynlonta data, $105M stock offering

ADC Therapeutics announced a $105 million offering after sharing what it called positive topline data from a Phase 2 trial of its cancer drug Zynlonta.

May 7, 2024

What the Sarepta decision means for Duchenne patients, the company, and the FDA

Sarepta Therapeutics always wins. That was a given, even before the Food and Drug Administration expanded approval of the company’s Duchenne muscular dystrophy drug on

June 21, 2024

Interoperability: The Missing Link to Combat Nurse Burnout

Elizabeth Anderson MSN, RN, Director of Clinical Experience and Solutions at Rauland The American Organization for Nursing Leadership recently published a report that reinforces the

August 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.